In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Discovery Genomics Inc.

www.discoverygenomics.net

Latest From Discovery Genomics Inc.

Deals Shaping the Medical Industry, April 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in March 2016.

BioPharmaceutical Medical Device

Start-Up Previews (2/05)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Convergence: What's Next at the Nexus?, features profiles of Direct-Haler, EndoBionics, Polymerix and X-Cell Medical. Plus these Start-Ups across Health Care: Discovery Genomics, FoldRx and Neuronetics.

Discovery Genomics Inc.

Discovery Genomics Inc.'s Sleeping Beauty transposon vector is non-viral, but it can integrate into the genome to achieve long-term expression. DGI uses it in two parts: the transposon vector carries the therapeutic genes, and the transposase enzyme moves it from the vector into the chromosome. When delivered to cells at the same time, the transposase cuts the therapeutic gene out of the vector and inserts it into the host chromosome, much like you cut and paste using a word processor.
BioPharmaceutical

Recent Dealmaking (10/2002)

Summarizing the month in European dealmaking.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Discovery Genomics Inc.
  • Senior Management
  • Scott R McIvor, PhD, Pres., CEO, & CSO
  • Contact Info
  • Discovery Genomics Inc.
    Phone: (612) 656-4484
    614 McKinley Pl. NE
    Minneapolis, MN 55413
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register